Sex differences in rat liver carcinogenesis are known following exposure to several hepatocarcinogens, including 2-acetylaminofluorene (2-AAF) and aflatoxin B1 (AFB1). Furthermore, hormones are important modifiers of rat liver carcinogenesis. Most previous studies focus on the importance of sex hormones in this process. Results from our laboratory indicates that also pituitary hormones are capable of modifying liver carcinogenesis. We hypothesize that sex hormones influence rat liver carcinogenesis via a hypothalamo-pituitary-liver axis, as we have previously demonstrated for the sex differentiated hepatic metabolism of steroid hormones. The mechanism by which hormones influence the various stages of rat liver carcinogenesis are unknown. Do the sex differences occur during initiation and/or during promotion? Is the sexual dimorphism in response to carcinogen treatment due to a sexually differentiated metabolism of the carcinogen, leading to differences in mutagenicity and/or toxicity of the carcinogen or are other mechanisms also involved? Our aim is to try to answer these questions by investigating the effects of pituitary hormones on early and later stages of liver carcinogens in the rat in vivo, as well on the in vitro rat liver metabolism of hepatocarcinogens, especially 2-AAF. The following experiments will be carried out concerning pituitary regulation of chemical carcinogenesis in rat liver in vivo: 1. Effects of continuous infusion of bovine GH and ovine prolactin on the 2-AAF selection in the RM-model. 2. Will neonatal and adult castration of male rats, with or without testosterone substitution, alter the response to 2-AAF selection in the RH-model? 3. Effects of in vivo inhibition of the N-OH-2-AAF sulfotransferase on the 2-AAF selection in the RM-model. 4. Influence of pituitary hormones on the initiation of rat liver carcinogenesis with AFB1 and 2-AAF. 5. Effects of hypophysectomy, with or without hormonal substitution, on the promotion/progression of rat liver carcinogenesis. 6. Studies concerning sex differences in, and hormonal regulation of, the mitoinhibitory and toxic effects of 2-AAF. A deeper knowledge concerning mechanisms behind hormonal control of liver carcinogenesis may be of relevance also for the understanding of the pathogenesis of other hormone dependent cancers such as breast and prostatic carcinoma.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA042054-02
Application #
3182837
Study Section
Chemical Pathology Study Section (CPA)
Project Start
1987-05-01
Project End
1990-04-30
Budget Start
1988-05-01
Budget End
1989-04-30
Support Year
2
Fiscal Year
1988
Total Cost
Indirect Cost
Name
Karolinska Institute
Department
Type
DUNS #
350582235
City
Stockholm
State
Country
Sweden
Zip Code
171 77
Porsch Hallstrom, I; Svensson, D; Blanck, A (1991) Sex-differentiated deoxycholic acid promotion of rat liver carcinogenesis is under pituitary control. Carcinogenesis 12:2035-40
Blanck, A; Eriksson, L C; Gustafsson, J A et al. (1991) Sex-differentiated and growth-hormone-regulated mitoinhibition in rat liver during treatment with 2-acetylaminofluorene and partial hepatectomy in the resistant hepatocyte model. Carcinogenesis 12:1259-64
Hallstrom, I P; Gustafsson, J A; Blanck, A (1991) Role of growth hormone in the regulation of the c-myc gene during progression of sex-differentiated rat liver carcinogenesis in the resistant hepatocyte model. Mol Carcinog 4:376-81
Cameron, R G; Blanck, A; Armstrong, D (1990) Sex differences in response to four promotion regimens in spite of common first cellular steps in the hepatocellular cancer process initiated by diethylnitrosamine. Cancer Lett 50:109-13
Lindhe, B; Porsch-Hallstrom, I; Gustafsson, J A et al. (1990) Effects of neonatal and adult castration and of testosterone substitution in male rats on growth of enzyme-altered hepatic foci in the resistant hepatocyte model. Cancer Res 50:2679-82
Moller, L; Torndal, U B; Eriksson, L C et al. (1989) The air pollutant 2-nitrofluorene as initiator and promoter in a liver model for chemical carcinogenesis. Carcinogenesis 10:435-40
Porsch-Hallstrom, I; Blanck, A; Eriksson, L C et al. (1989) Expression of the c-myc, c-fos and c-rasHa protooncogenes during sex-differentiated rat liver carcinogenesis in the resistant hepatocyte model. Carcinogenesis 10:1793-800
Elliott, T J; Eisen, H N (1988) Allorecognition of purified major histocompatibility complex glycoproteins by cytotoxic T lymphocytes. Proc Natl Acad Sci U S A 85:2728-32
Moller, L; Tornquist, S; Beije, B et al. (1987) Metabolism of the carcinogenic air pollutant 2-nitrofluorene in the isolated perfused rat lung and liver. Carcinogenesis 8:1847-52
Blanck, A; Hansson, T; Eriksson, L C et al. (1987) Growth hormone modifies the growth rate of enzyme-altered hepatic foci in male rats treated according to the resistant hepatocyte model. Carcinogenesis 8:1585-8